Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Neutrophil-to-lymphocyte ratio combined with CURB-65 score to identify patients at high risk of 30-day mortality in community-acquired pneumonia through the emergency medical department of tertiary hospitals.

Created on 25 Jun 2026

Authors

Léna Schroeder Chaidron, Emilie Creutz, Kelly Cremer, Andrea Penaloza-Baeza, Annie Robert, Jean Cyr Yombi

Published in

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. Pages 108920. Jun 24, 2026. Epub Jun 24, 2026.

Abstract

This study aimed to assess the additive value of the neutrophil-to-lymphocyte ratio (NLR) to the CURB-65 score for improving identification of elderly patients with community-acquired pneumonia (CAP) at high risk of mortality in the emergency medical department (EMD).
This retrospective study included consecutive patients with CAP admitted to the EMD of a Belgian tertiary hospital between 2020 and 2022. Patients were divided into 3 age subgroups: <65 years, 65-79 years and ≥80 years. Clinical and laboratory data were collected from medical records. Hierarchical models of CURB-65 with and without NLR were compared using multivariate logistic regression to assess the added predictive value of NLR on 30-day mortality.
869 patients were included. 30-day mortality increased with age (<65 years: 2.0%; 65-79 years: 8.8%; ≥80 years: 19.7%). NLR ≥16 was associated with 30-day mortality and adding NLR to the CURB-65 score improved 30-day mortality prediction compared to the CURB-65 alone in both 65-79 years and ≥80 years subgroups.
NLR ≥16 has an additional prognostic value to the CURB-65 score in EMD patients with CAP aged ≥65 years. The CURB-65-NLR≥16 score may improve mortality risk stratification among elderly patients by classifying them into intermediate, high and very-high risk categories.

PMID:
42341906
Bibliographic data and abstract were imported from PubMed on 25 Jun 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 12
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement